204 related articles for article (PubMed ID: 38577780)
1. Targeting Intracellular Bacteria with Dual Drug-loaded Lactoferrin Nanoparticles.
Andima M; Boese A; Paul P; Koch M; Loretz B; Lehr CM
ACS Infect Dis; 2024 May; 10(5):1696-1710. PubMed ID: 38577780
[TBL] [Abstract][Full Text] [Related]
2. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
[TBL] [Abstract][Full Text] [Related]
3. Carboplatin- and Etoposide-Loaded Lactoferrin Protein Nanoparticles for Targeting Cancer Stem Cells in Retinoblastoma In Vitro.
Narayana RVL; Jana P; Tomar N; Prabhu V; Nair RM; Manukonda R; Kaliki S; Coupland SE; Alexander J; Kalirai H; Kondapi AK; Vemuganti GK
Invest Ophthalmol Vis Sci; 2021 Nov; 62(14):13. PubMed ID: 34784412
[TBL] [Abstract][Full Text] [Related]
4. Lactoferrin and Its Derived Peptides: An Alternative for Combating Virulence Mechanisms Developed by Pathogens.
Zarzosa-Moreno D; Avalos-Gómez C; Ramírez-Texcalco LS; Torres-López E; Ramírez-Mondragón R; Hernández-Ramírez JO; Serrano-Luna J; de la Garza M
Molecules; 2020 Dec; 25(24):. PubMed ID: 33302377
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin-loaded nanoparticles against vancomycin intermediate and methicillin resistant Staphylococcus aureus strains.
Simon A; Moreira MLA; Costa IFJB; de Sousa VP; Rodrigues CR; da Rocha E Lima LMT; Sisnande T; do Carmo FA; Leal ICR; Dos Santos KRN; da Silva LCRP; Cabral LM
Nanotechnology; 2020 Sep; 31(37):375101. PubMed ID: 32470951
[TBL] [Abstract][Full Text] [Related]
6. Potent antibacterial nanoparticles for pathogenic bacteria.
Lai HZ; Chen WY; Wu CY; Chen YC
ACS Appl Mater Interfaces; 2015 Jan; 7(3):2046-54. PubMed ID: 25584802
[TBL] [Abstract][Full Text] [Related]
7. Intracellular infection-responsive macrophage-targeted nanoparticles for synergistic antibiotic immunotherapy of bacterial infection.
Dai X; Li Y; Liu X; Zhang Y; Gao F
J Mater Chem B; 2024 May; 12(21):5248-5260. PubMed ID: 38712662
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronate/lactoferrin layer-by-layer-coated lipid nanocarriers for targeted co-delivery of rapamycin and berberine to lung carcinoma.
Kabary DM; Helmy MW; Elkhodairy KA; Fang JY; Elzoghby AO
Colloids Surf B Biointerfaces; 2018 Sep; 169():183-194. PubMed ID: 29775813
[TBL] [Abstract][Full Text] [Related]
9. Combating Intracellular Pathogens with Nanohybrid-Facilitated Antibiotic Delivery.
Bose RJC; Tharmalingam N; Choi Y; Madheswaran T; Paulmurugan R; McCarthy JR; Lee SH; Park H
Int J Nanomedicine; 2020; 15():8437-8449. PubMed ID: 33162754
[TBL] [Abstract][Full Text] [Related]
10. Bactericidal effect of bovine lactoferrin, LFcin, LFampin and LFchimera on antibiotic-resistant Staphylococcus aureus and Escherichia coli.
Flores-Villaseñor H; Canizalez-Román A; Reyes-Lopez M; Nazmi K; de la Garza M; Zazueta-Beltrán J; León-Sicairos N; Bolscher JG
Biometals; 2010 Jun; 23(3):569-78. PubMed ID: 20195887
[TBL] [Abstract][Full Text] [Related]
11. pH-Responsive Lipid-Dendrimer Hybrid Nanoparticles: An Approach To Target and Eliminate Intracellular Pathogens.
Maji R; Omolo CA; Agrawal N; Maduray K; Hassan D; Mokhtar C; Mackhraj I; Govender T
Mol Pharm; 2019 Nov; 16(11):4594-4609. PubMed ID: 31593478
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy.
Ali OM; Bekhit AA; Khattab SN; Helmy MW; Abdel-Ghany YS; Teleb M; Elzoghby AO
Colloids Surf B Biointerfaces; 2020 Apr; 188():110824. PubMed ID: 32023511
[TBL] [Abstract][Full Text] [Related]
13. A novel lactoferrin-modified β-cyclodextrin nanocarrier for brain-targeting drug delivery.
Ye Y; Sun Y; Zhao H; Lan M; Gao F; Song C; Lou K; Li H; Wang W
Int J Pharm; 2013 Dec; 458(1):110-7. PubMed ID: 24126038
[TBL] [Abstract][Full Text] [Related]
14. Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson's disease treatment.
Bi C; Wang A; Chu Y; Liu S; Mu H; Liu W; Wu Z; Sun K; Li Y
Int J Nanomedicine; 2016; 11():6547-6559. PubMed ID: 27994458
[TBL] [Abstract][Full Text] [Related]
15. Biological activity of lactoferrin-functionalized biomimetic hydroxyapatite nanocrystals.
Nocerino N; Fulgione A; Iannaccone M; Tomasetta L; Ianniello F; Martora F; Lelli M; Roveri N; Capuano F; Capparelli R
Int J Nanomedicine; 2014; 9():1175-84. PubMed ID: 24623976
[TBL] [Abstract][Full Text] [Related]
16. Nuclear and cytoplasmic delivery of lactoferrin in glioma using chitosan nanoparticles: Cellular location dependent-action of lactoferrin.
Tammam SN; Azzazy HME; Lamprecht A
Eur J Pharm Biopharm; 2018 Aug; 129():74-79. PubMed ID: 29802982
[TBL] [Abstract][Full Text] [Related]
17. Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma.
Pandey V; Gajbhiye KR; Soni V
Drug Deliv; 2015 Feb; 22(2):199-205. PubMed ID: 24467582
[TBL] [Abstract][Full Text] [Related]
18. Studies on lactoferrin nanoparticles of gambogic acid for oral delivery.
Zhang ZH; Wang XP; Ayman WY; Munyendo WL; Lv HX; Zhou JP
Drug Deliv; 2013 Feb; 20(2):86-93. PubMed ID: 23495734
[TBL] [Abstract][Full Text] [Related]
19. Calcium pectinate and hyaluronic acid modified lactoferrin nanoparticles loaded rhein with dual-targeting for ulcerative colitis treatment.
Luo R; Lin M; Fu C; Zhang J; Chen Q; Zhang C; Shi J; Pu X; Dong L; Xu H; Ye N; Sun J; Lin D; Deng B; McDowell A; Fu S; Gao F
Carbohydr Polym; 2021 Jul; 263():117998. PubMed ID: 33858583
[TBL] [Abstract][Full Text] [Related]
20. Synergistic action of lactoferrin in enhancing the safety and effectiveness of docetaxel treatment against prostate cancer.
Muj C; Mukhopadhyay S; Jana P; Kondapi AK
Cancer Chemother Pharmacol; 2023 May; 91(5):375-387. PubMed ID: 36977771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
